Statera Biopharma, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 +NaN% -€150.44M +1,218.8% N/A -€24.16M +452.2% N/A
    €0.00 +NaN% -€11.41M +295.0% N/A -€4.38M +2,010.3% N/A
    €0.00 +NaN% -€2.89M -7.3% N/A -€207.34K -94.8% N/A
    €0.00 +NaN% -€3.12M -62.8% N/A -€3.98M -30.2% N/A
    €0.00 +NaN% -€8.37M +265.1% N/A -€5.70M +31.2% N/A
    €0.00 +NaN% -€2.29M -79.0% N/A -€4.35M -58.3% N/A
    €0.00 +NaN% -€10.90M -100.8% N/A -€10.42M -99.9% N/A
    €0.00 +NaN% €1.41B -109.4% N/A -€12.47B -37.4% N/A
    €0.00 +NaN% -€14.89B -5.3% N/A -€19.93B +11.9% N/A
    €0.00 -100.0% -€15.73B +354.3% N/A -€17.81B +22.1% N/A
    €7.58B +∞% -€3.46B -68.7% -45.7% -0.46 pp -€14.58B +35.6% -192.3% -1.9 pp
    €0.00 +NaN% -€11.06B -8.6% N/A -€10.76B -9.0% N/A
    €0.00 -€12.10B N/A -€11.82B N/A

    Notifications